• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Vaporox

Vaporox

The new standard in wound care.

  • VHT
  • Patients
  • Providers
  • News
  • Contact

News

Vaporox Announces FDA Clearance for Its Next Generation Wound Care Medical Device

March 27, 2023

Vaporox, a Denver based medical device company, has received clearance from the US Food and Drug Administration for its next generation VHT-200 medical device system for healing chronic wounds, which are wounds that do not respond to conventional wound treatment, meeting a significant unmet medical need for millions of sufferers of diabetic foot ulcers.

Filed Under: News

Colorado BioScience Association’s Post on LinkedIn

December 13, 2022

In our new BioScience Colorado Magazine, CBSA highlights how companies have raised critical capital. Colorado’s angel community, including Rockies Venture Club, played an integral role in Vaporox Inc.‘s fundraising efforts. After taking the CEO role and forging a commercialization strategy that capitalized on the company’s remarkable clinical results, Alan Sage found major success in the angel market.

Filed Under: News

Vaporox Medical Director, Dr. Dustin Kruse is elected to the American Board of Foot & Ankle Surgery Board

May 5, 2022

Filed Under: News

Vaporox Selected for LSI Investor Event

February 4, 2022

Filed Under: News

Bioventus Invests in Vaporox

June 24, 2021

Filed Under: News

Vaporox CEO selected as one of 20 CEOs “innovating in medtech”

April 25, 2021

Filed Under: News

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Footer

  • LinkedIn
  • Twitter
  • YouTube

(303) 558-5145
info@vaporox.com
8375 S. Willow Street, Ste. 500
Lone Tree, CO 80124

  • VHT
  • Patients
  • Providers
  • News
  • Careers
  • About
  • Contact

Subscribe for the latest VHT updates

© 2023 Vaporox. All rights reserved.